Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lisata Therapeutics Inc.

    NASDAQ: LSTA · Real-Time Price · USD
    2.60
    0.10 (4.21%)
    At close: Jun 16, 2025, 2:06 PM

    Lisata Therapeutics Statistics

    Share Statistics

    Lisata Therapeutics has 8.6M shares outstanding. The number of shares has increased by 3.76% in one year.

    Shares Outstanding

    n/a
    		 8.6M

    Shares Change (YoY)

    n/a
    		 3.76%

    Shares Change (QoQ)

    n/a
    		 2.68%

    Owned by Institutions (%)

    n/a
    		 9.43%

    Shares Floating

    n/a
    		 6.72M

    Failed to Deliver (FTD) Shares

    n/a
    		 12,950

    FTD / Avg. Volume

    n/a
    		 104.66%

    Short Selling Information

    The latest short interest is 28.38K, so 0.33% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 28.38K

    Short % of Shares Out

    n/a
    		 0.33%

    Short % of Float

    n/a
    		 0.4%

    Short Ratio (days to cover)

    n/a
    		 1.56

    Valuation Ratios

    The PE ratio is -1.24 and the forward PE ratio is -2.64. Lisata Therapeutics's PEG ratio is 0.18.

    PE Ratio

    n/a
    		 -1.24

    Forward PE

    n/a
    		 -2.64

    PS Ratio

    n/a
    		 24.82

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 0.84

    P/FCF Ratio

    n/a
    		 -1.28

    PEG Ratio

    n/a
    		 0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Lisata Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.16, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.16

    Quick Ratio

    n/a
    		 6.16

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $38,461.54

    Profits Per Employee

    n/a
    		 $-768,653.85

    Employee Count

    n/a
    		 26

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -798K

    Effective Tax Rate

    n/a
    		 3.84%

    Stock Price Statistics

    The stock price has increased by -30.56% in the last 52 weeks. The beta is 1, so Lisata Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1

    52-Week Price Change

    n/a
    		 -30.56%

    50-Day Moving Average

    n/a
    		 2.38

    200-Day Moving Average

    n/a
    		 2.7

    Relative Strength Index (RSI)

    n/a
    		 48.59

    Average Volume (20 Days)

    n/a
    		 12,373

    Income Statement

    In the last 12 months, Lisata Therapeutics had revenue of 1M and earned -19.98M in profits. Earnings per share was -2.4.

    Revenue

    n/a
    		 1M

    Gross Profit

    n/a
    		 826K

    Operating Income

    n/a
    		 -22.41M

    Net Income

    n/a
    		 -19.98M

    EBITDA

    n/a
    		 -22.23M

    EBIT

    n/a
    		 -22.41M

    Earnings Per Share (EPS)

    n/a
    		 -2.4
    Full Income Statement

    Balance Sheet

    The company has 16.21M in cash and 137K in debt, giving a net cash position of 16.07M.

    Cash & Cash Equivalents

    n/a
    		 16.21M

    Total Debt

    n/a
    		 137K

    Net Cash

    n/a
    		 16.07M

    Retained Earnings

    n/a
    		 -548.07M

    Total Assets

    n/a
    		 28.98M

    Working Capital

    n/a
    		 24.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -19.36M and capital expenditures 0, giving a free cash flow of -19.36M.

    Operating Cash Flow

    n/a
    		 -19.36M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -19.36M

    FCF Per Share

    n/a
    		 -2.32
    Full Cash Flow Statement

    Margins

    Gross margin is 82.6%, with operating and profit margins of -2240.9% and -1998.5%.

    Gross Margin

    n/a
    		 82.6%

    Operating Margin

    n/a
    		 -2240.9%

    Pretax Margin

    n/a
    		 -2078.3%

    Profit Margin

    n/a
    		 -1998.5%

    EBITDA Margin

    n/a
    		 -2223.5%

    EBIT Margin

    n/a
    		 -2240.9%

    FCF Margin

    n/a
    		 -1935.6%

    Dividends & Yields

    LSTA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LSTA is $15, which is 500% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 500%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Sep 15, 2022. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Sep 15, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -23.83

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist